Gsa Capital Partners LLP Assembly Biosciences, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.35 - $2.29 $183,375 - $311,059	-135,834 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.46 - $2.45 $198,317 - $332,793	135,834 New	135,834 $280,000
Q4 2020 Feb 03, 2021	SELL	$4.87 - $17.29 $113,013 - $401,231	-23,206 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$15.08 - $27.04 $349,946 - $627,490	23,206 New	23,206 $382,000
Q1 2018 May 11, 2018	SELL	$41.7 - $64.16 $296,320 - $455,920	-7,106 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $203,089 - $354,660	7,106	7,106 $322,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.